What’s New

Latest News

News
Emerging Treatments Expand Atopic Dermatitis Options in the US
03/07/2026
Rebecca Mashaw
The expanding portfolio of atopic dermatitis therapies underscores a pivotal transition from suboptimal traditional treatments toward safer, more individualized care across age groups.
The expanding portfolio of atopic dermatitis therapies underscores a pivotal transition from suboptimal traditional treatments toward safer, more individualized care across age groups.
The expanding portfolio of...
03/07/2026
Allergy & Immunology
Allergy & Immunology
News
CNS-Active Polypharmacy Affects 10 Percent of Medicare MTM Enrollees in the US
03/06/2026
Hannah Musick
In a nationally representative Medicare Medication Therapy Management (MTM) cohort, 10.7% of enrollees experienced central nervous system (CNS)-active polypharmacy, yet only about one-third completed a comprehensive medication review,...
In a nationally representative Medicare Medication Therapy Management (MTM) cohort, 10.7% of enrollees experienced central nervous system (CNS)-active polypharmacy, yet only about one-third completed a comprehensive medication review,...
In a nationally representative...
03/06/2026
First Report Managed Care
First Report Managed Care
News
FDA Approves Pembrolizumab Plus Paclitaxel for Platinum-Resistant Ovarian Cancer in the US
03/06/2026
Hannah Musick
The US Food and Drug Administration (FDA) has approved pembrolizumab in combination with paclitaxel ± bevacizumab for PD-L1–positive platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma, based on improved...
The US Food and Drug Administration (FDA) has approved pembrolizumab in combination with paclitaxel ± bevacizumab for PD-L1–positive platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma, based on improved...
The US Food and Drug...
03/06/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
orange pill bottle antidepressant depression major depressive disorder MDD
News
Decision Tool Reduces Antidepressant Dropout in Major Depressive Disorder
03/06/2026
Brionna Mendoza
A clinical decision-support system called PETRUSHKA was found to improve antidepressant continuation in adults with major depressive disorder (MDD). The tool also improved depression and anxiety symptoms.
A clinical decision-support system called PETRUSHKA was found to improve antidepressant continuation in adults with major depressive disorder (MDD). The tool also improved depression and anxiety symptoms.
A clinical decision-support...
03/06/2026
Psych Congress Network
Psych Congress Network
News
Cemiplimab Improves Disease-Free Survival in High-Risk Cutaneous Squamous Cell Carcinoma
03/05/2026
Stephanie Holland
Results from the phase 3 C-POST trial demonstrated that adjuvant cemiplimab significantly improved disease-free survival compared with placebo among patients with high-risk cSCC.
Results from the phase 3 C-POST trial demonstrated that adjuvant cemiplimab significantly improved disease-free survival compared with placebo among patients with high-risk cSCC.
Results from the phase 3 C-POST...
03/05/2026
Oncology
Oncology
News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
Pharmacy Learning Network
Analysis
Why “Medical Necessity” Is the #1 Audit Vulnerability for Skin Substitutes
03/05/2026
Jennifer J. Spector, DPM, FACFAS
Across Medicare audits, denials of skin substitute (CTP) claims most often hinge on a single issue: medical necessity. Even when products are FDA-cleared and correctly billed, auditors routinely find that the clinical record fails...
Across Medicare audits, denials of skin substitute (CTP) claims most often hinge on a single issue: medical necessity. Even when products are FDA-cleared and correctly billed, auditors routinely find that the clinical record fails...
Across Medicare audits, denials...
03/05/2026
Wounds
Wounds

Latest Research

Cover Story Jan/Feb
The Dermatologist
Forward Focus: Top Trends in Dermatology for 2026
Vol. 34, Issue 1, Issue March 2026

HMP Global Learning Network

Featured Interviews

Ira Zackon, MD
Videos
Real-World Analysis Finds Venetoclax-Based Induction Effective for Very Elderly Patients With Acute Myeloid Leukemia
03/02/2026
Ira Zackon, MD
Ira Zackon, MD, shared results from a large real-world analysis which found venetoclax plus a hypomethylating agent is a feasible and effective therapeutic option for patients with AML aged 70 years and older.
Ira Zackon, MD, shared results from a large real-world analysis which found venetoclax plus a hypomethylating agent is a feasible and effective therapeutic option for patients with AML aged 70 years and older.
Ira Zackon, MD, shared results...
03/02/2026
Oncology
Pediatric Video Tutorial: Communicating With Deaf Patients Part 2
Videos
Pediatric Video Tutorial: Communicating With Deaf Patients Part 2
03/02/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
With invaluable insights from a certified interpreter for the deaf, part two of this four-part series rapidly reviews what medical professionals really need to know, and what their deaf patients wish their caregivers knew.
With invaluable insights from a certified interpreter for the deaf, part two of this four-part series rapidly reviews what medical professionals really need to know, and what their deaf patients wish their caregivers knew.
With invaluable insights from a...
03/02/2026
EMSWorld
Allen Kaplan
RESEARCH INSIGHTS
Diagnostic Challenges and Clinical Pitfalls in HAE
03/02/2026
Allen P. Kaplan, MD
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common diagnostic pitfalls in hereditary angioedema, including misinterpretation of complement testing, confusion with histaminergic angioedema, and challenges in identifying HAE with normal C1 inhibitor.
Dr Allen Kaplan reviews common...
03/02/2026
Allergy & Immunology
Zeymer title card
Author Interview
Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization: An Interview With Uwe Zeymer, MD
02/27/2026
Uwe Zeymer, MD
Dr Uwe Zeymer shares background and insights on his article, "Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization."
Dr Uwe Zeymer shares background and insights on his article, "Hospital Outcomes of Patients With Acute Myocardial Infarction-Related Cardiogenic Shock With and Without Revascularization."
Dr Uwe Zeymer shares background...
02/27/2026
Journal of Invasive Cardiology
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
02/27/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
02/27/2026
Vascular Disease Management
tourniquet stop the bleed DeBoer
Videos
Pediatric Video Tutorial: Stop the Bleed Part 2—Tourniquet Tips
01/30/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets, whether for little ones or big people, practice and proper placement can be lifesavers.
When it comes to tourniquets,...
01/30/2026
EMSWorld
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Conference Coverage
Clinical Strategies for the Assessment and Management of Antibody-Drug Conjugate Toxicities
01/30/2026
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, reviewed the mechanisms, expanding clinical use, and payload-driven toxicities of antibody-drug conjugates, emphasizing practical strategies for toxicity recognition, management, and optimizing patient...
Sri Kota, MSN, BA, APN, AGNP-C,...
01/30/2026
Oncology Learning Network APP Institute
CTP News Desk hero image
Viewpoints
Avoiding Audits and Making Sure You Get Paid
01/30/2026
Caroline E. Fife, MD, FAAFP, CWS, FUHM
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits, Dr. Fife advises clinicians on a prudent product selection process and how to avoid being audited.
Noting an increase in audits,...
01/30/2026
Wounds
Alison Schram, MD, Memorial Sloan Kettering Cancer Center
Videos
Treating NRG1 Fusion-Positive Non-Small Cell Lung Cancer
01/02/2026
Alison Schram, MD
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the...
01/02/2026
Oncology
Matthew Regulski, DPM, FFPM, RCPS (Glasgow), DABMSP
Viewpoints
Cutting Costs, Raising Standards: The Case for Evidence-Based CTP Use
12/30/2025
Matthew J. Regulski, DPM, ABMSP, CMET, FAPWH(c)
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are...
12/30/2025
Wounds

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use